세계의 소아 헬스 케어 시장 : 치료, 적응증, 최종 사용자별 예측(2025-2030년)

The Paediatric Healthcare Market was valued at USD 107.01 billion in 2023, expected to reach USD 114.55 billion in 2024, and is projected to grow at a CAGR of 7.53%, to USD 177.94 billion by 2030.

The pediatric healthcare market encompasses various services tailored to the unique medical needs of children, from newborns to adolescents. This sector is essential because it addresses specific developmental, nutritional, and psychosocial requirements that are vastly different from adults. Pediatric healthcare extends beyond treatment to preventive care, diagnostics, and therapeutic interventions, with end-use involving hospitals, clinics, and specialty care centers. Key growth influencers include technological advancements in medical devices and pharmaceuticals, rising awareness of child health, and increasing incidences of pediatric diseases. The surge in demand for telemedicine, owing to convenience and enhanced accessibility, presents a lucrative opportunity for stakeholders. Additionally, the thriving focus on pediatric research for chronic illnesses offers significant potential for innovation. However, challenges like stringent regulatory frameworks, high costs of advanced healthcare solutions, and disparities in access to quality healthcare facilities pose obstacles to market growth. The industry must address these challenges, notably by advocating for more inclusive and supportive healthcare policies. Innovation should focus on developing cost-effective medical devices and enhancing telehealth solutions to reach underserved populations. Furthermore, the integration of artificial intelligence (AI) in diagnostics and patient management systems can enhance personalized care. For business growth, investing in pediatric vaccine development, especially for emergent viral threats, and exploring partnerships with tech companies for smart-health solutions can be prudent. Additionally, there is considerable potential in developing wearable health technology adapted for children to monitor health metrics continuously, thus fostering proactive health management. In nature, the pediatric healthcare market is competitive yet promising, characterized by ongoing research and a strong drive towards better health outcomes for children globally. To harness these dynamics, companies should remain updated on technological trends and regulatory changes while prioritizing innovation and strategic collaborations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Paediatric Healthcare Market

The Paediatric Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of deaths attributed to viral infections and malnutrition
  • Rising government support and initiatives to promote pediatric health
  • Growing awareness among child parents for adequate treatment
• Market Restraints
  • Ethical concerns and small size of the study population
• Market Opportunities
  • Growing research and development in technological advancements
  • Surge in medical expenditure in emerging economies
• Market Challenges
  • Lack of pediatricians across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Paediatric Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Paediatric Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Paediatric Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Paediatric Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Paediatric Healthcare Market

A detailed market share analysis in the Paediatric Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Paediatric Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Paediatric Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Paediatric Healthcare Market

A strategic analysis of the Paediatric Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Paediatric Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Aveanna Healthcare, LLC., Becton, Dickinson and Company, bioMerieux SA, Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Enviva Inc., Gilead Sciences, Inc., Glaxosmithkline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Interim HealthCare Inc., Janssen Global Services LLC, Johnson & Johnson Services, Inc., Medexus Pharmaceuticals, Inc., Medtronic PLC, Merck KGaA, Novartis AG, Olympus Corporation, ORPHELIA Pharma, Pfizer Inc., Proveca Ltd., Royal Philips, Sanofi S.A, Siemens AG, Strykar Corporation, The Procter & Gamble Company, Thermo Fisher Scientific, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Paediatric Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment, market is studied across Immunotherapy, Medications, and Surgeries.
• Based on Indication, market is studied across Asthma & Allergies, Cardiac Disorders, Genetic Disorders, and Metabolic Disorders.
• Based on End-User, market is studied across Ambulatory Care Centers, Homecare Settings, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of deaths attributed to viral infections and malnutrition
    • 5.1.1.2. Rising government support and initiatives to promote pediatric health
    • 5.1.1.3. Growing awareness among child parents for adequate treatment
  • 5.1.2. Restraints
    • 5.1.2.1. Ethical concerns and small size of the study population
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing research and development in technological advancements
    • 5.1.3.2. Surge in medical expenditure in emerging economies
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of pediatricians across the globe
• 5.2. Market Segmentation Analysis
  • 5.2.1. Treatment: Expanding usage of pediatric healthcare for immunotherapy for a myriad of health conditions
  • 5.2.2. Indication: Growing need for effective, age-appropriate medications in pediatric healthcare to manage asthma & allergies
  • 5.2.3. End-User: Growing usage of pediatric healthcare across hospitals & clinics that offer a wide range of services
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Paediatric Healthcare Market, by Treatment

• 6.1. Introduction
• 6.2. Immunotherapy
• 6.3. Medications
• 6.4. Surgeries

7. Paediatric Healthcare Market, by Indication

• 7.1. Introduction
• 7.2. Asthma & Allergies
• 7.3. Cardiac Disorders
• 7.4. Genetic Disorders
• 7.5. Metabolic Disorders

8. Paediatric Healthcare Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Care Centers
• 8.3. Homecare Settings
• 8.4. Hospitals & Clinics

9. Americas Paediatric Healthcare Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Paediatric Healthcare Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Paediatric Healthcare Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Cortica Closes USD 75 Million in New Funding Round and Acquires Springtide Child Development
  • 12.3.2. Pediatric Behavioral Health Provider Bend Health Moves Out of Stealth Mode with USD 32M in Funding
  • 12.3.3. Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AstraZeneca PLC
• 3. Aveanna Healthcare, LLC.
• 4. Becton, Dickinson and Company
• 5. bioMerieux SA
• 6. Boehringer Ingelheim International GmbH
• 7. Eisai Co., Ltd.
• 8. Eli Lilly and Company
• 9. Enviva Inc.
• 10. Gilead Sciences, Inc.
• 11. Glaxosmithkline PLC
• 12. GP Pharm, S.A.
• 13. Henin Lukinz Pvt. Ltd.
• 14. Interim HealthCare Inc.
• 15. Janssen Global Services LLC
• 16. Johnson & Johnson Services, Inc.
• 17. Medexus Pharmaceuticals, Inc.
• 18. Medtronic PLC
• 19. Merck KGaA
• 20. Novartis AG
• 21. Olympus Corporation
• 22. ORPHELIA Pharma
• 23. Pfizer Inc.
• 24. Proveca Ltd.
• 25. Royal Philips
• 26. Sanofi S.A
• 27. Siemens AG
• 28. Strykar Corporation
• 29. The Procter & Gamble Company
• 30. Thermo Fisher Scientific, Inc.
• 31. Viatris Inc.